Shaoxing Xingxin New Material Co.,Ltd (SHE:001358)
28.41
-0.67 (-2.30%)
Jan 26, 2026, 1:15 PM CST
Revenue by Product
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2017 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2017 - 2019 |
Piperazine Series | 405.91M | Log In | Log In | Log In | Log In | Upgrade |
Piperazine Series Growth | -26.00% | Log In | Log In | Log In | Log In | Upgrade |
Amide Series | 32.43M | Log In | Log In | Log In | Log In | Upgrade |
Amide Series Growth | 28.65% | Log In | Log In | Log In | Log In | Upgrade |
Other | 29.80M | Log In | Log In | Log In | Log In | Upgrade |
Other Growth | -47.25% | Log In | Log In | Log In | Log In | Upgrade |
Other Business | - | Log In | Log In | Log In | Log In | Upgrade |
Other Business Growth | - | Log In | Log In | Log In | Log In | Upgrade |
Piperazine Series - N-Hydroxyethylpiperazine | - | Log In | Log In | Log In | Log In | Upgrade |
Piperazine Series - N-Hydroxyethylpiperazine Growth | - | Log In | Log In | Log In | Log In | Upgrade |
Piperazine Series - Triethylene Diamine | - | Log In | Log In | Log In | Log In | Upgrade |
Piperazine Series - Triethylene Diamine Growth | - | Log In | Log In | Log In | Log In | Upgrade |
Piperazine Series - Desulfurization and Decarbonization Agent | - | Log In | Log In | Log In | Log In | Upgrade |
Piperazine Series - Desulfurization and Decarbonization Agent Growth | - | Log In | Log In | Log In | Log In | Upgrade |
Piperazine Series - N-Methylpiperazine | - | Log In | Log In | Log In | Log In | Upgrade |
Piperazine Series - N-Methylpiperazine Growth | - | Log In | Log In | Log In | Log In | Upgrade |
Piperazine Series - N-Ethylpiperazine | - | Log In | Log In | Log In | Log In | Upgrade |
Piperazine Series - N-Ethylpiperazine Growth | - | Log In | Log In | Log In | Log In | Upgrade |
Amide Series - N,N-Dimethylpropane Amide | - | Log In | Log In | Log In | Log In | Upgrade |
Amide Series - N,N-Dimethylpropane Amide Growth | - | Log In | Log In | Log In | Log In | Upgrade |
Piperazine Series - Anhydrous Piperazine | - | Log In | Log In | Log In | Log In | Upgrade |
Piperazine Series - Anhydrous Piperazine Growth | - | Log In | Log In | Log In | Log In | Upgrade |
Piperazine Series - Other Piperazine Series Product | - | Log In | Log In | Log In | Log In | Upgrade |
Piperazine Series - Other Piperazine Series Product Growth | - | Log In | Log In | Log In | Log In | Upgrade |
Other | 29.80M | Log In | Log In | Log In | Log In | Upgrade |
Other Growth | -47.25% | Log In | Log In | Log In | Log In | Upgrade |
Revenue by Geography
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2017 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2017 - 2019 |
Other | - | Log In | Log In | Log In | Log In | Upgrade |
Other Growth | - | Log In | Log In | Log In | Log In | Upgrade |
China | 468.14M | Log In | Log In | Log In | Log In | Upgrade |
China Growth | -25.72% | Log In | Log In | Log In | Log In | Upgrade |
Asia | - | Log In | Log In | Log In | Log In | Upgrade |
Asia Growth | - | Log In | Log In | Log In | Log In | Upgrade |
Europe | - | Log In | Log In | Log In | Log In | Upgrade |
Europe Growth | - | Log In | Log In | Log In | Log In | Upgrade |
Other | - | Log In | Log In | Log In | Log In | Upgrade |
Other Growth | - | Log In | Log In | Log In | Log In | Upgrade |